<?xml version="1.0" encoding="UTF-8"?>
<p>Augmenting ADCC activity is a novel research direction in cancer research. Target cell killing activities triggered by ADCC mAbs can be substantially increased by the addition of ADCC-promoting agents, which has attracted substantial attention in cancer research [
 <xref rid="B134-viruses-12-00276" ref-type="bibr">134</xref>,
 <xref rid="B135-viruses-12-00276" ref-type="bibr">135</xref>]. Means of augmentation of these responses in cancer research might shed light on influenza research as well. Different strategies for enhancing ADCC were developed and employed in clinical trials in recent studies.
</p>
